ยินดีต้อนรับกลับมา
เข้าร่วม CoinTime
เข้าสู่ระบบ email
สร้างบัญชี email
ตรวจสอบกล่องจดหมายของคุณ
Nautilus Biotech
About
Nautilus Biotech is a clinical-stage biopharmaceutical company focused on developing therapeutic proteins.
- 11 - 50
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- €7.25M
- Industries
- Biopharma,Biotechnology,Therapeutics
- Founded date
- Jan 1, 1999
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Nautilus Biotech is a biotechnology company. The company has a pipeline of therapeutic proteins with improved profiles. The company's products include Belerofon, an injectable and orally available interferon alpha for use in the treatment of chronic Hepatitis C infection; and Vitatropin, an injectable and orally available human growth hormone (hGH) for use in the treatment of growth deficiencies. Nautilus Biotech S.A. sells therapeutic proteins, including interferons, hormones, growth factors, and enzymes in France and internationally. The company's protein engineering technology improves the pharmacology profile and administration route of blockbuster protein drugs. Nautilus Biotech S.A. was founded in 1999 and is based in Evry, France.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Apr 30, 2007 | Series Unknown | $11.30M | 1 | — | — | Detail |
| Mar 3, 2005 | Series Unknown | €7.25M | 1 | — | — | Detail |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Matignon Investissement & Gestion
|
— | Series Unknown |
